Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Editorial (Thematic Issue: Cow’s Milk Allergy: Where do we Stand?)
Volume: 14 Issue: 1
Author(s): Kostas N. Priftis
Affiliation:
Export Options
About this article
Cite this article as:
Priftis N. Kostas, Editorial (Thematic Issue: Cow’s Milk Allergy: Where do we Stand?), Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (1) . https://dx.doi.org/10.2174/1871530314666140121142447
DOI https://dx.doi.org/10.2174/1871530314666140121142447 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
37
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Premature Ageing Prevention: Limitations and Perspectives of Pharmacological Interventions
Current Drug Targets Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications
Cardiovascular & Hematological Agents in Medicinal Chemistry New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species
Current Topics in Medicinal Chemistry Recent Advances in Controlled Release Pulmonary Therapy
Current Drug Delivery Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Current Pharmaceutical Design Management of Obesity in Pregnancy
Current Women`s Health Reviews Carnosine and Diabetic Nephropathy
Current Medicinal Chemistry Assessment of Prescription Pattern in Asthma Therapy at Shamli Hospitals
Reviews on Recent Clinical Trials microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Editorial [Hot topic: Brave New World? Arrestin Pathway Bias in Drug Design (Guest Editor: Bradley T. Andresen)]
Endocrine, Metabolic & Immune Disorders - Drug Targets Network Insights into the Genes Regulated by Hepatocyte Nuclear Factor 4 in Response to Drug Induced Perturbations: A Review
Current Drug Discovery Technologies The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy
Current Medicinal Chemistry Stability Indicating Method for Known and Unknown Impurities Profiling for Vildagliptin in Vildagliptin Tablet
Current Pharmaceutical Analysis Mitochondria Associated Membranes (MAMs): Emerging Drug Targets for Diabetes
Current Medicinal Chemistry Graphical Abstracts:
Current Hypertension Reviews Preeclampsia and the Future Development of Cardiovascular Disease: A Review
Current Women`s Health Reviews Elevated Levels of Soluble Fibrin in Patients with Thrombosis or a Pre- Thrombotic State
Vascular Disease Prevention (Discontinued)